m6A Target Gene Information
General Information of the m6A Target Gene (ID: M6ATAR00371)
Full List of m6A Methylation Regulator of This Target Gene and Corresponding Disease/Drug Response(s)
POLK
can be regulated by the following regulator(s), and cause disease/drug response(s). You can browse detail information of regulator(s) or disease/drug response(s).
Browse Regulator
Browse Disease
Methyltransferase-like 3 (METTL3) [WRITER]
Representative RNA-seq result indicating the expression of this target gene regulated by METTL3 | ||
Cell Line | mouse embryonic stem cells | Mus musculus |
Treatment: METTL3-/- ESCs
Control: Wild type ESCs
|
GSE145309 | |
Regulation |
|
logFC: 8.09E-01 p-value: 1.19E-26 |
More Results | Click to View More RNA-seq Results | |
Representative RIP-seq result supporting the interaction between POLK and the regulator | ||
Cell Line | MDA-MB-231 | Homo sapiens |
Regulation | logFC: 1.90E+00 | GSE60213 |
In total 1 item(s) under this regulator | ||||
Experiment 1 Reporting the m6A Methylation Regulator of This Target Gene | [1] | |||
Response Summary | Methylation at the 6 position of adenosine (m6A) in RNA is rapidly (within 2 min) and transiently induced at DNA damage sites in response to ultraviolet irradiation. This modification occurs on numerous poly(A)+ transcripts and is regulated by the methyltransferase METTL3 and the demethylase FTO. DNA DNA polymerase kappa (Pol Kappa/POLK), which has been implicated in both nucleotide excision repair and trans-lesion synthesis, required the catalytic activity of METTL3 for immediate localization to ultraviolet-induced DNA damage sites. | |||
Target Regulation | Up regulation | |||
Responsed Disease | Exposure to radiation | ICD-11: PH73 | ||
Cell Process | DNA repair | |||
Nucleotide excision repair (hsa03420) | ||||
In-vitro Model | A-375 | Amelanotic melanoma | Homo sapiens | CVCL_0132 |
U2OS | Osteosarcoma | Homo sapiens | CVCL_0042 | |
HEK293T | Normal | Homo sapiens | CVCL_0063 | |
HeLa | Endocervical adenocarcinoma | Homo sapiens | CVCL_0030 | |
MEF (Mouse embryonic fibroblasts) | ||||
U2OS | Osteosarcoma | Homo sapiens | CVCL_0042 | |
Fat mass and obesity-associated protein (FTO) [ERASER]
In total 1 item(s) under this regulator | ||||
Experiment 1 Reporting the m6A Methylation Regulator of This Target Gene | [1] | |||
Response Summary | Methylation at the 6 position of adenosine (m6A) in RNA is rapidly (within 2 min) and transiently induced at DNA damage sites in response to ultraviolet irradiation. This modification occurs on numerous poly(A)+ transcripts and is regulated by the methyltransferase METTL3 and the demethylase FTO. DNA DNA polymerase kappa (Pol Kappa/POLK), which has been implicated in both nucleotide excision repair and trans-lesion synthesis, required the catalytic activity of METTL3 for immediate localization to ultraviolet-induced DNA damage sites. | |||
Target Regulation | Up regulation | |||
Responsed Disease | Exposure to radiation | ICD-11: PH73 | ||
Cell Process | DNA repair | |||
Nucleotide excision repair (hsa03420) | ||||
In-vitro Model | A-375 | Amelanotic melanoma | Homo sapiens | CVCL_0132 |
U2OS | Osteosarcoma | Homo sapiens | CVCL_0042 | |
HEK293T | Normal | Homo sapiens | CVCL_0063 | |
HeLa | Endocervical adenocarcinoma | Homo sapiens | CVCL_0030 | |
MEF (Mouse embryonic fibroblasts) | ||||
U2OS | Osteosarcoma | Homo sapiens | CVCL_0042 | |
Exposure to radiation [ICD-11: PH73]
In total 2 item(s) under this disease | ||||
Experiment 1 Reporting the m6A-centered Disease Response | [1] | |||
Response Summary | Methylation at the 6 position of adenosine (m6A) in RNA is rapidly (within 2 min) and transiently induced at DNA damage sites in response to ultraviolet irradiation. This modification occurs on numerous poly(A)+ transcripts and is regulated by the methyltransferase METTL3 and the demethylase FTO. DNA DNA polymerase kappa (Pol Kappa/POLK), which has been implicated in both nucleotide excision repair and trans-lesion synthesis, required the catalytic activity of METTL3 for immediate localization to ultraviolet-induced DNA damage sites. | |||
Responsed Disease | Exposure to radiation [ICD-11: PH73] | |||
Target Regulator | Fat mass and obesity-associated protein (FTO) | ERASER | ||
Target Regulation | Up regulation | |||
Cell Process | DNA repair | |||
Nucleotide excision repair (hsa03420) | ||||
In-vitro Model | A-375 | Amelanotic melanoma | Homo sapiens | CVCL_0132 |
U2OS | Osteosarcoma | Homo sapiens | CVCL_0042 | |
HEK293T | Normal | Homo sapiens | CVCL_0063 | |
HeLa | Endocervical adenocarcinoma | Homo sapiens | CVCL_0030 | |
MEF (Mouse embryonic fibroblasts) | ||||
U2OS | Osteosarcoma | Homo sapiens | CVCL_0042 | |
Experiment 2 Reporting the m6A-centered Disease Response | [1] | |||
Response Summary | Methylation at the 6 position of adenosine (m6A) in RNA is rapidly (within 2 min) and transiently induced at DNA damage sites in response to ultraviolet irradiation. This modification occurs on numerous poly(A)+ transcripts and is regulated by the methyltransferase METTL3 and the demethylase FTO. DNA DNA polymerase kappa (Pol Kappa/POLK), which has been implicated in both nucleotide excision repair and trans-lesion synthesis, required the catalytic activity of METTL3 for immediate localization to ultraviolet-induced DNA damage sites. | |||
Responsed Disease | Exposure to radiation [ICD-11: PH73] | |||
Target Regulator | Methyltransferase-like 3 (METTL3) | WRITER | ||
Target Regulation | Up regulation | |||
Cell Process | DNA repair | |||
Nucleotide excision repair (hsa03420) | ||||
In-vitro Model | A-375 | Amelanotic melanoma | Homo sapiens | CVCL_0132 |
U2OS | Osteosarcoma | Homo sapiens | CVCL_0042 | |
HEK293T | Normal | Homo sapiens | CVCL_0063 | |
HeLa | Endocervical adenocarcinoma | Homo sapiens | CVCL_0030 | |
MEF (Mouse embryonic fibroblasts) | ||||
U2OS | Osteosarcoma | Homo sapiens | CVCL_0042 | |